WO2004113375A3 - Antimicrobial compositions and uses thereof - Google Patents

Antimicrobial compositions and uses thereof Download PDF

Info

Publication number
WO2004113375A3
WO2004113375A3 PCT/GB2004/002597 GB2004002597W WO2004113375A3 WO 2004113375 A3 WO2004113375 A3 WO 2004113375A3 GB 2004002597 W GB2004002597 W GB 2004002597W WO 2004113375 A3 WO2004113375 A3 WO 2004113375A3
Authority
WO
WIPO (PCT)
Prior art keywords
antimicrobial compositions
antibiotic
targeting
bacterium
polypeptide
Prior art date
Application number
PCT/GB2004/002597
Other languages
French (fr)
Other versions
WO2004113375A2 (en
Inventor
Heather Fairhead
Original Assignee
Phico Therapeutics Ltd
Heather Fairhead
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phico Therapeutics Ltd, Heather Fairhead filed Critical Phico Therapeutics Ltd
Publication of WO2004113375A2 publication Critical patent/WO2004113375A2/en
Publication of WO2004113375A3 publication Critical patent/WO2004113375A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A polynucleotide encoding a polypeptide having α/β-type SASP activity and a delivery system therefor capable of targeting a bacterium, and an antibiotic, as a combined preparation for simultaneous, separate or sequential use as a medicament.
PCT/GB2004/002597 2003-06-20 2004-06-18 Antimicrobial compositions and uses thereof WO2004113375A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0314469A GB0314469D0 (en) 2003-06-20 2003-06-20 Antimicrobial compositions and uses thereof
GB0314469.8 2003-06-20

Publications (2)

Publication Number Publication Date
WO2004113375A2 WO2004113375A2 (en) 2004-12-29
WO2004113375A3 true WO2004113375A3 (en) 2005-02-24

Family

ID=27637061

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2004/002597 WO2004113375A2 (en) 2003-06-20 2004-06-18 Antimicrobial compositions and uses thereof

Country Status (2)

Country Link
GB (1) GB0314469D0 (en)
WO (1) WO2004113375A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715416D0 (en) * 2007-08-07 2007-09-19 Phico Therapeutics Ltd Modified bacteriophage
FR2936710B1 (en) 2008-10-07 2011-01-07 Ceva Sante Animale ANTIPROLACTINIC VETERINARY COMPOSITION FOR RUMINANTS
GB201417808D0 (en) * 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modified bacteriophage
GB201417810D0 (en) 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modifying bacteriophage
GB201417805D0 (en) * 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modifield bacteriophage
GB201600075D0 (en) * 2016-01-03 2016-02-17 Glaxosmithkline Biolog Sa Immunogenci composition
US10781441B2 (en) 2016-04-08 2020-09-22 Phico Therapeutics Ltd Modifying bacteriophage
LT3440200T (en) 2016-04-08 2021-05-25 Phico Therapeutics Ltd Modified bacteriophage

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766892A (en) * 1994-04-05 1998-06-16 Exponential Biotherapies, Inc. Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system together with an antibiotic
WO2002040678A1 (en) * 2000-11-17 2002-05-23 Phico Therapeutics Ltd. Small acid-soluble spore protein and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766892A (en) * 1994-04-05 1998-06-16 Exponential Biotherapies, Inc. Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system together with an antibiotic
WO2002040678A1 (en) * 2000-11-17 2002-05-23 Phico Therapeutics Ltd. Small acid-soluble spore protein and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RUZAL SANDRA M ET AL: "Osmoresistance of spores from Bacillus subtilis and the effect of ssp mutations", MICROBIOLOGY (READING), vol. 140, no. 8, 1994, pages 2173 - 2177, XP001204256 *

Also Published As

Publication number Publication date
GB0314469D0 (en) 2003-07-23
WO2004113375A2 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
WO2005000878A3 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
WO2005082399A3 (en) Treatment of bacterial infections
WO2002070438A3 (en) Compositions for delivering bisphosphonates
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
EP2279662A3 (en) 5,7,4'-trihydroxy-3',5'-dimethoxyflavone as an antibacterial agent
EP1283050A3 (en) Improved therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
WO2008092690A8 (en) Aminoglycoside antibiotics targeting bacterial 16s ribosomal rna
WO2007007095A3 (en) Pharmaceutical compositions comprising a tgf-beta superfamily member
IL171914A0 (en) Variants of il-18bp, their preparation and pharmaceutical compositions containing them
EP1019084A4 (en) Novel antimicrobial polypeptide and methods of use
WO2005046579A3 (en) Defined dose therapeutic phage
WO2004113375A3 (en) Antimicrobial compositions and uses thereof
MXPA05005338A (en) Methods of administering dalbavancin for treatment of bacterial infections.
WO2003017924A3 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
TW200730579A (en) Antimicrobial plastics composition with low elution rate and with long period of activity
AP2005003375A0 (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them.
WO2004067563A8 (en) Peptide inhibitors of toxins derived from ll-37
MXPA03007124A (en) Targetted anti-tumor drug delivery systems.
GB0028130D0 (en) Polypeptide and uses thereof
WO2002040518A8 (en) Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant
WO2006009907A3 (en) Isoxazolidine compounds for treatment of bacterial infections
AU2002214197A1 (en) Macrolides
MXPA01012427A (en) Antibiotics ge 23077, pharmaceutically acceptable salts and compositions, and use thereof.
WO2007070536A3 (en) 7-quinolyl ketolide antibacterial agents
AU2003274676A1 (en) Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase